drugset / Trial / NCT06973889

Evaluation of IgY Antibody Efficacy in Egg Yolk Against Helicobacter Pylori in Bacterial Elimination and Clinical Symptoms Improvement of Gastrointestinal Patients

NCT06973889

Phase 2 Completed 60 enrolled Mashhad University of Medical Sciences
RandomizedParallel-groupTriple-blindTreatment

Summary

1. Investigating its effectiveness in removing bacteria in invivo conditions 2. Investigating the effectiveness in improving the clinical symptoms of patients

Timeline

Start
2023-12-04
Primary completion
2024-12-30
Completion
2025-01-21

Drugs

EvaluationDrugModalityDoseRoute
Subject IgY Protein / enzyme biologic 2 g
Background Amoxicillin Other / unclassified 2000 mg
Background Clarithromycin Small molecule 1000 mg
Background Omeprazole Other / unclassified 40 mg